Severe pancytopenia caused by trifluridine/tipiracil in patients with
metastatic colorectal cancer and an impaired renal function: A case
Although the incidence of hematological toxicity due to FTD/TPI
treatment is high, the incidence of severe adverse events has been
reported to be relatively low. However, it should be noted that patients
with renal impairment are prone to severe hematological adverse events.